Anticoagulant therapy and pregnancy

Area of Science:

• Reproductive Medicine
• Obstetrics
• Hematology

Background:

• Anticoagulant therapies, including low-dose aspirin, are used in pregnancy for conditions like recurrent miscarriage and pre-eclampsia.
• While effective for antiphospholipid syndrome, the broad efficacy of anticoagulants for all pregnancy complications remains uncertain.
• Thrombogenic factors such as protein deficiencies and hyperhomocysteinemia are known causes of pregnancy loss.

Purpose of the Study:

• To evaluate the effectiveness of low-dose aspirin and heparin combination therapy in improving live birth rates.
• To determine if this therapy is beneficial for unexplained recurrent pregnancy loss, even in the absence of antiphospholipid syndrome.

Main Methods:

• Review of recent data on anticoagulant therapy in pregnancy.
• Analysis of the efficacy of low-dose aspirin and heparin combination in preventing recurrent pregnancy loss.
• Assessment of outcomes in women with and without antiphospholipid syndrome.

Main Results:

• Low-dose aspirin and heparin combination therapy shows effectiveness in preventing recurrent pregnancy loss in women with antiphospholipid syndrome.
• Anticoagulant therapy can maintain pregnancy in cases of unexplained recurrent pregnancy loss.
• Approximately 70% of recurrent pregnancy losses have unclear or multifactorial etiologies.

Conclusions:

• Low-dose aspirin and heparin combination therapy is a viable option for managing unexplained recurrent pregnancy loss.
• This therapeutic approach can be beneficial for women experiencing pregnancy loss without antiphospholipid antibody syndrome.